Finance

Lists
2561:HKG
Visen Pharmaceuticals
HK$18.23
-0.33%
(-0.060) 1D
Oct 15, 4:00:00 PM GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 2561...
Open
HK$18.27
High
HK$18.34
Low
HK$17.88
Mkt. cap
2.07B
Avg. vol.
7.99K
Volume
8.20K
52-wk high
HK$43.30
52-wk low
HK$17.88
EPS
-HK$2.36
No. of employees
102
Open
HK$18.27
High
HK$18.34
Low
HK$17.88
Mkt. cap
2.07B
Avg. vol.
7.99K
Volume
8.20K
52-wk high
HK$43.30
52-wk low
HK$17.88
EPS
-HK$2.36
No. of employees
102
News stories
From web sources and news partners
About Visen Pharmaceuticals
CEO-
Employees102
Founded2018
Headquarters-
SectorBiotechnology
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-375.50K
-375.50K
17.41M
17.41M
Cost of goods sold
73.00K
73.00K
8.24M
8.24M
Cost of revenue
73.00K
73.00K
8.24M
8.24M
Research and development expenses
23.43M
23.43M
18.69M
18.69M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
43.14M
43.14M
34.69M
34.69M
Operating expense
66.57M
66.57M
53.37M
53.37M
Total operating expenses
66.65M
66.65M
61.61M
61.61M
Operating income
-67.02M
-67.02M
-44.21M
-44.21M
Other non operating income
-306.50K
-306.50K
-500.00
-500.00
EBT including unusual items
-67.70M
-67.70M
-52.05M
-52.05M
EBT excluding unusual items
-67.70M
-67.70M
-52.05M
-52.05M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-67.70M
-67.70M
-52.05M
-52.05M
Net profit margin
18,029.56%
18,029.56%
-299.04%
-299.04%
Earnings per share
-
-
-
-
Interest and investment income
3.32M
3.32M
2.38M
2.38M
Interest expense
-529.50K
-529.50K
-1.02M
-1.02M
Net interest expenses
2.79M
2.79M
1.37M
1.37M
Depreciation and amortization charges
-
-
-
-
EBITDA
-66.91M
-66.91M
-44.01M
-44.01M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google apps